← Leaderboards
Mary C Farach-Carson
University Of Delaware
$9,131,545
Attributed
$13,287,980
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,287,980 · 12
By mechanism
R01$8,714,544 · 4
P01$3,386,732 · 2
P20$744,685 · 4
R56$404,519 · 1
R03$37,500 · 1
Top collaborators
- Liyun Wang6 shared
- Xinqiao Jia5 shared
- Robert Lee Witt5 shared
- Isabelle M.A. Lombaert4 shared
Most similar at University Of Delaware
Same institution · by research overlap
- Liyun Wang$7,918,152
- Xinqiao Jia$11,387,325
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTissuesEnzymesStructurePerlecanSignal TransductionResponseSiteHeparitin SulfateHeparan Sulfate ProteoglycanLaboratoriesBiologyBasement MembraneResourcesDesignMolecularBoneHydrogelsAngiogenesisDisease ProgressionAnimal ModelBaseExtracellular MatrixIn Vivo
Grant awards (40)
Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models$680,277
R01 · FY2025 · DE · contact PI
Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models$666,672
R01 · FY2024 · DE · contact PI
Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models$680,277
R01 · FY2023 · DE · contact PI
Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models$727,581
R01 · FY2022 · DE · contact PI
Cell-Based Therapy in Minipig Model of Radiation-Induced Xerostomia$404,519
R56 · FY2020 · DE · contact PI
Mechanosensing in the Bone Lacunar-Canalicular System$401,643
R01 · FY2019 · AR
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$300,563
P01 · FY2019 · CA · contact PI
Mechanosensing in the Bone Lacunar-Canalicular System$471,769
R01 · FY2018 · AR
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$307,584
P01 · FY2018 · CA · contact PI
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$2,669
P01 · FY2018 · CA · contact PI
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$1,782
P01 · FY2018 · CA · contact PI
Mechanosensing in the Bone Lacunar-Canalicular System$478,773
R01 · FY2017 · AR
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$281,091
P01 · FY2017 · CA · contact PI
Mechanosensing in the Bone Lacunar-Canalicular System$392,558
R01 · FY2016 · AR
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$307,895
P01 · FY2016 · CA · contact PI
Supplement to R01 Titled: Mechanosensing in the Bone Lacunar-Canalicular System$64,887
R01 · FY2016 · AR
Functional Assembly of Salivary Cells to Relieve Xerostomia$601,763
R01 · FY2015 · DE · contact PI
Mechanosensing in the Bone Lacunar-Canalicular System$410,853
R01 · FY2015 · AR
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis$309,802
P01 · FY2015 · CA · contact PI
Functional Assembly of Salivary Cells to Relieve Xerostomia$666,138
R01 · FY2014 · DE · contact PI
Functional Assembly of Salivary Cells to Relieve Xerostomia$25,744
R01 · FY2014 · DE · contact PI
Functional Assembly of Salivary Cells to Relieve Xerostomia$577,692
R01 · FY2013 · DE · contact PI
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis$351,931
P01 · FY2013 · CA · contact PI
Functional Assembly of Salivary Cells to Relieve Xerostomia$631,848
R01 · FY2012 · DE · contact PI
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis$368,255
P01 · FY2012 · CA · contact PI
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis$369,377
P01 · FY2011 · CA · contact PI
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis$381,407
P01 · FY2010 · CA · contact PI
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis$404,376
P01 · FY2009 · CA · contact PI
PERLECAN AND HEPARANASE IN CARTILAGE GROWTH AND HEALING$315,866
P20 · FY2009 · RR · contact PI
ELECTROSPUN COLLAGEN SCAFFOLDS FOR 3D CELLULAR MODELS FOR ANTI-NEOPLASTIC AGENTS$54,591
P20 · FY2009 · RR · contact PI
PERLECAN AND HEPARANASE IN CARTILAGE GROWTH AND HEALING$330,141
P20 · FY2008 · RR · contact PI
ELECTROSPUN COLLAGEN SCAFFOLDS FOR 3D CELLULAR MODELS FOR ANTI-NEOPLASTIC AGENTS$44,087
P20 · FY2008 · RR · contact PI
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$274,766
R01 · FY2003 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$55,316
R01 · FY2003 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$320,906
R01 · FY2002 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$258,995
R01 · FY2001 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$53,007
R01 · FY2001 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$21,625
R01 · FY2001 · DE
REGULATION OF CALCIUM CHANNEL EXPRESSION IN OSTEOBLASTS$251,454
R01 · FY2000 · DE
GROWTH FACTOR BIOAVAILABILITY AND GINGIVAL OVERGROWTH$37,500
R03 · FY2000 · DE